Genomic heterogeneity as a barrier to precision oncology in urothelial cancer Journal Article


Authors: Clinton, T. N.; Chen, Z.; Wise, H.; Lenis, A. T.; Chavan, S.; Donoghue, M. T. A.; Almassi, N.; Chu, C. E.; Dason, S.; Rao, P.; Rodrigues, J. A.; Vasani, N. B.; Ridouani, F.; Rosenberg, J. E.; Bajorin, D. F.; Teo, M. Y.; Bochner, B. H.; Berger, M. F.; Ostrovnaya, I.; Pietzak, E. J.; Iyer, G.; Gao, S. P.; Hu, W.; Al-Ahmadie, H. A.; Solit, D. B.
Article Title: Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
Abstract: Precision oncology relies on the accurate molecular characterization of individual patients with cancer at the time of treatment initiation. However, tumor molecular profiles are not static, and cancers continually evolve because of ongoing mutagenesis and clonal selection. Here, we performed genomic analyses of primary tumors, metastases, and plasma collected from individual patients to define the concordance of actionable genomic alterations and to identify drivers of metastatic disease progression. We observed a high degree of discordance of actionable genomic alterations, with 23% discordant between primary and metastatic disease sites. Among chromatin-modifying genes, ARID1A mutations, when discordant, were exclusive to the metastatic tumor samples. Our findings indicate that the high degree of lesion-to-lesion genomic heterogeneity may be a barrier to precision oncology approaches for bladder cancer and that circulating tumor DNA profiling may be preferred to tumor sequencing for a subset of patients. © 2022 The Author(s)
Keywords: genetics; mutation; metastasis; pathology; bladder cancer; bladder tumor; urinary bladder neoplasms; urothelial carcinoma; genomics; personalized medicine; high throughput sequencing; high-throughput nucleotide sequencing; fgfr3; arid1a; humans; human; precision medicine; circulating tumor dna; genomic heterogeneity; cell-free dna; cp: cancer
Journal Title: Cell Reports
Volume: 41
Issue: 12
ISSN: 2211-1247
Publisher: Cell Press  
Date Published: 2022-12-20
Start Page: 111859
Language: English
DOI: 10.1016/j.celrep.2022.111859
PUBMED: 36543146
PROVIDER: scopus
PMCID: PMC9882421
DOI/URL:
Notes: Article -- Export Date: 3 January 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    653 Bajorin
  2. David Solit
    775 Solit
  3. Gopakumar Vasudeva Iyer
    335 Iyer
  4. Bernard Bochner
    461 Bochner
  5. Wenhuo Hu
    60 Hu
  6. Sizhi Gao
    47 Gao
  7. Michael Forman Berger
    760 Berger
  8. Jonathan Eric Rosenberg
    503 Rosenberg
  9. Min Yuen   Teo
    102 Teo
  10. Hannah Christina Wise
    12 Johnsen
  11. Eugene J Pietzak
    113 Pietzak
  12. Shawn Dason
    15 Dason
  13. Naresh B Vasani
    4 Vasani
  14. Shweta S Chavan
    34 Chavan
  15. Nima Almassi
    26 Almassi
  16. Timothy Nguyen Clinton
    19 Clinton
  17. Pavitra Nagesh Rao
    4 Rao
  18. Andrew Thomas Lenis
    23 Lenis
  19. Carissa Ellen Chu
    13 Chu